SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-202930
Filing Date
2017-06-14
Accepted
2017-06-14 07:03:06
Documents
16
Period of Report
2017-06-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d352977d8k.htm 8-K 14719
2 EX-99.1 d352977dex991.htm EX-99.1 11743
3 EX-99.2 d352977dex992.htm EX-99.2 18464
4 GRAPHIC g352977ex99_1s10g1.jpg GRAPHIC 146909
5 GRAPHIC g352977ex99_1s11g1.jpg GRAPHIC 341054
6 GRAPHIC g352977ex99_1s12g1.jpg GRAPHIC 234400
7 GRAPHIC g352977ex99_1s13g1.jpg GRAPHIC 210337
8 GRAPHIC g352977ex99_1s1g1.jpg GRAPHIC 73416
9 GRAPHIC g352977ex99_1s2g1.jpg GRAPHIC 435147
10 GRAPHIC g352977ex99_1s3g1.jpg GRAPHIC 213438
11 GRAPHIC g352977ex99_1s4g1.jpg GRAPHIC 237756
12 GRAPHIC g352977ex99_1s5g1.jpg GRAPHIC 156381
13 GRAPHIC g352977ex99_1s6g1.jpg GRAPHIC 180676
14 GRAPHIC g352977ex99_1s7g1.jpg GRAPHIC 167301
15 GRAPHIC g352977ex99_1s8g1.jpg GRAPHIC 177415
16 GRAPHIC g352977ex99_1s9g1.jpg GRAPHIC 112073
  Complete submission text file 0001193125-17-202930.txt   3747280
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 17910251
SIC: 2834 Pharmaceutical Preparations